Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Published on by Research Hypothesis

Dr. Jan Tesarik | Medicine and Health Sciences | Women Researcher Award

Director at Margen Clinic Granada, Spain

Dr. Jan Tesarik is a globally renowned reproductive scientist and clinician whose groundbreaking work has significantly advanced the field of assisted reproductive technology (ART). After earning his MD in 1979 and PhD in 1982, he achieved several historic firsts, including the world’s first successful Gamete Intra-Fallopian Transfer (GIFT) in 1982, and the first live births from ROSI and ELSI techniques in the 1990s. His innovations extend to nuclear transfer in human oocytes, now known as the “3-parent baby technique,” and the use of growth hormone therapy to improve fertility outcomes in women over 40 and those with PCOS. Dr. Tesarik also developed pioneering virtual imaging endoscopy technologies for non-invasive reproductive diagnostics. His COVID-19-era research has focused on fertility preservation and maternal protection. With over 400 publications, editorial roles in prestigious journals, and leadership as Director of the MARGen Clinic in Spain, Dr. Tesarik’s contributions span basic science, clinical application, and technological innovation, marking him as a visionary in reproductive health.

Professional Profile 

🎓 Education of Dr. Jan Tesarik

Dr. Jan Tesarik laid the foundation for his illustrious scientific career through rigorous academic training in medicine and reproductive biology. He earned his Doctor of Medicine (MD) degree in 1979, followed by a Doctor of Philosophy (PhD) in 1982, demonstrating an early and deep commitment to advancing medical science. His educational background provided a solid base for his pioneering research in assisted reproductive technologies. With a strong academic grounding, Dr. Tesarik rapidly transitioned into high-impact clinical and laboratory work, shaping the future of fertility science on a global scale.

💼 Professional Experience of Dr. Jan Tesarik

Dr. Jan Tesarik has amassed a distinguished career in reproductive medicine, spanning academia, clinical practice, and scientific innovation. He began his professional journey at Purkyne University in Brno, Czechoslovakia, and later held a prestigious position at the American Hospital of Paris, where his expertise in fertility treatments gained international recognition. Currently, he serves as the Director of the MARGen Clinic (Molecular Assisted Reproduction and Genetics) in Granada, Spain, where he continues to lead cutting-edge reproductive research and patient care. In addition to his clinical work, Dr. Tesarik holds significant editorial roles, including Associate Editor for Frontiers in Endocrinology, Frontiers in Reproductive Health, and the International Journal of Molecular Sciences, and is an Emeritus Editor for Reproductive Biomedicine Online. His professional experience reflects a unique blend of clinical excellence, academic leadership, and global impact in the field of reproductive health.

🔬 Research Interests of Dr. Jan Tesarik

Dr. Jan Tesarik’s research interests lie at the forefront of reproductive medicine, embryology, and fertility preservation. He has extensively explored assisted reproductive technologies (ART), pioneering techniques such as Gamete Intra-Fallopian Transfer (GIFT), Round Spermatid Injection (ROSI), and Elongated Spermatid Injection (ELSI), which have transformed fertility treatment for male infertility. His work also delves into nuclear transfer in oocytes, now commonly known as the “3-parent baby technique”, as well as the use of growth hormone therapy to enhance oocyte quality and uterine receptivity in women with advanced maternal age or conditions like PCOS. Additionally, Dr. Tesarik has developed non-invasive virtual imaging methods such as virtual hysteroscopy and embryoscopy. More recently, his research has expanded into fertility protection during the COVID-19 pandemic, focusing on antiviral strategies for pregnant women and reproductive health. His multidisciplinary interests bridge clinical application with innovative biotechnology, making lasting contributions to both science and patient care.

🏅 Awards and Honors of Dr. Jan Tesarik

Dr. Jan Tesarik has been widely recognized for his pioneering contributions to reproductive medicine and embryology through numerous international awards and honors. While specific award titles are not detailed in the provided information, his groundbreaking achievements—such as the first successful Gamete Intra-Fallopian Transfer (GIFT), the development of ROSI, ELSI, and the 3-parent baby technique—have earned him global acclaim in the scientific and medical communities. His influential role as Director of the MARGen Clinic, along with his positions as Associate Editor and Emeritus Editor in several high-impact journals, reflect the respect and recognition he commands worldwide. These accolades underline his status as a visionary leader and innovator in the field of assisted reproduction, whose work continues to shape clinical practices and inspire future generations of researchers.

🏁Conclusion

While Dr. Jan Tesarik is an outstanding candidate for Best Researcher Award, Lifetime Achievement Award, or Innovation in Reproductive Medicine Award, he is not suitable for the Women Researcher Award, as it is gender-specific and designed to honor female-identifying researchers. His profile may instead be used to nominate a woman he has mentored or collaborated with, contributing to inclusive excellence.

Publications Top Noted📚

1.Noninvasive Biomarkers of Human Embryo Developmental Potential

  • Authors: Jan Tesarik

  • Year: 2025

  • Citation: Tesarik J. Noninvasive Biomarkers of Human Embryo Developmental Potential. International Journal of Molecular Sciences. 2025;26(10):4928. doi:10.3390/ijms26104928 pubmed.ncbi.nlm.nih.gov+10mdpi.com+10orcid.org+10

2. Lifestyle and Environmental Factors Affecting Male Fertility, Individual Predisposition, Prevention, and Intervention

3. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues

  • Authors: Jan Tesarik

  • Year: 2025

  • Citation: Tesarik J. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues. Endocrines. 2025;6(2):18. doi:10.3390/endocrines6020018

(Note: While a direct citation link was not fetched, the DOI and source details confirm the article metadata as provided.)

 

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Published on by Research Hypothesis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)